MADISON, N.J., Nov. 13 /PRNewswire-FirstCall/ -- Wyeth announced today that it will present at the Credit Suisse First Boston Healthcare Conference on Wednesday, November 15, 2006 at 12:30 p.m. Eastern Time. Presenting for Wyeth will be Robert R. Ruffolo, Jr., Ph.D., Senior Vice President, Wyeth and President, Wyeth Research.
Wyeth’s presentation will be webcast live for investors at www.wyeth.com and available for replay following the conference.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, and Fort Dodge Animal Health.
Wyeth
CONTACT: Media, Douglas Petkus, +1-973-660-5218, or Investor, JustinVictoria, +1-973-660-5340, both of Wyeth
Web site: http://www.wyeth.com/
